Evidence map›Paper›PMID 29907652›Full record

Observational studyJournal of the American Heart Association2018

Cardiac Resynchronization Therapy and Clinical Outcomes in Continuous Flow Left Ventricular Assist Device Recipients.

Rakesh Gopinathannair, Henri Roukoz, Adarsh Bhan, Ashwin Ravichandran, Mustafa M Ahmed, Dmitry Familtsev, Geetha Bhat, Jennifer Cowger, Munazzah Abdullah, Chirag Sandesara and 4 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Guideline
  4. Trial
  5. Article
  6. Review
  7. Atrial fibrillation in continuous flow-left ventricular assist device (CF-LVAD) patients: impact on pathophysiology.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Ventricular Arrhythmias in Patients With Left Ventricular Assist Device (LVAD).Current treatment options in cardiovascular medicine · 2019
    Review
  16. Review
  17. Article
  18. Review
  19. Re-Thinking Re-Synching in Left Ventricular Assist Device Recipients.Journal of the American Heart Association · 2018
    Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Rakesh GopinathannairUniversity of Louisville, Louisville, KY rakesh.gopinathannair@louisville.edu drrakeshg@yahoo.com.
Henri RoukozUniversity of Minnesota, Minneapolis, MN.
Adarsh BhanAdvocate Christ Medical Center, Oak Lawn, IL.
Ashwin RavichandranSt. Vincent Heart Center, Indianapolis, IN.
Mustafa M AhmedUniversity of Florida, Gainesville, FL.
Dmitry FamiltsevUniversity of Arizona, Tucson, AZ.
Geetha BhatAdvocate Christ Medical Center, Oak Lawn, IL.
Jennifer CowgerHenry Ford Hospital, Detroit, MI.
Munazzah AbdullahAdvocate Christ Medical Center, Oak Lawn, IL.
Chirag SandesaraInova Heart and Vascular Institute, Fairfax, VA.
Rahul DhawanUniversity of Louisville, Louisville, KY.
Emma J BirksUniversity of Louisville, Louisville, KY.
Jaimin R TrivediUniversity of Louisville, Louisville, KY.
Mark S SlaughterUniversity of Louisville, Louisville, KY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany patients with heart failure continue cardiac resynchronization therapy (CRT) after continuous flow left ventricular assist device (CF-LVAD) implant. We report the first multicenter study to assess the impact of CRT on clinical outcomes in CF-LVAD patients. METHODS AND

resultsAnalysis was performed on 488 patients (58±13 years, 81% male) with an implantable cardioverter defibrillator (ICD) (n=223) or CRT-D (n=265) who underwent CF-LVAD implantation at 5 centers from 2007 to 2015. Effects of CRT on mortality, hospitalizations, and ventricular arrhythmia incidence were compared against CF-LVAD patients with an ICD alone. Baseline differences were noted between the 2 groups in age (60±12 versus 55±14,

conclusionsIn this large, multicenter CF-LVAD cohort, continued CRT was not associated with improved survival, hospitalizations, incidence of ventricular arrhythmia and ICD therapies, and was related to a significantly higher number of pulse generator changes.

Indexed as

Cardiac Resynchronization TherapyHeart-Assist DevicesVentricular Function, LeftAdultAgedArrhythmias, CardiacFemaleHeart FailureHumansIncidenceMaleMiddle AgedProsthesis DesignProsthesis ImplantationRetrospective StudiesRisk Factorscardiac resynchronization therapyheart failureimplanted cardioverter defibrillatorleft ventricular assist deviceventricular arrhythmia

Identifiers

PMID29907652
PMCPMC6220540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.